Clinical Trial Update: A Single Ascending Dose of HRS-4029 in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 single ascending dose study of HRS-4029 in healthy subjects is underway, with Acute Ischemic Stroke listed as the related condition in the trial recor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• HRS-4029

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Acute Ischemic Stroke | Phase 1 | Status: NOT_YET_RECRUITING